SIFI Portfolio
Various Ophthalmology Conditions
MarketedIntegration (Acquired)
Key Facts
Indication
Various Ophthalmology Conditions
Phase
Marketed
Status
Integration (Acquired)
Company
About Faes Farma
Faes Farma is a leading Spanish pharmaceutical group with a mission to transform health through passion, science, and innovation, achieving €627 million in revenue in 2025 with 23% year-over-year growth. Its strategy is built on a vertically integrated model, a focus on key therapeutic molecules like Bilastine and Calcifediol, and strategic acquisitions to bolster international presence and leadership in ophthalmology. The company aims to be at the forefront of excellence in health and well-being, supported by a dual business model spanning human pharmaceuticals and animal nutrition.
View full company profileOther Various Ophthalmology Conditions Drugs
| Drug | Company | Phase |
|---|---|---|
| Edol Portfolio | Faes Farma | Marketed |